2021
DOI: 10.1016/j.ejmech.2021.113780
|View full text |Cite
|
Sign up to set email alerts
|

Design, synthesis and evaluation of heteroaryldihydropyrimidine analogues bearing spiro ring as hepatitis B virus capsid protein inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 13 publications
(10 citation statements)
references
References 34 publications
0
10
0
Order By: Relevance
“…This reaction was well supported with 15 mol% chiral catalyst based on secondary amine (Cat.12) and 15 mol% of benzoic acid as an additive in toluene at room temperature. Under optimal reaction conditions target spirocyclopentaneoxindole derivatives (20) were obtained in excellent reaction yields (up to 86 %) and stereoselectivities (dr > 90 : 1, and ee > 99 %) (Scheme 16). [108] First, functionalized oxindole performs a Si-face nucleophilic attack on iminium-activated α,β-unsaturated alde-Scheme 24.…”
Section: Double Michael Cascade Reactionsmentioning
confidence: 99%
See 1 more Smart Citation
“…This reaction was well supported with 15 mol% chiral catalyst based on secondary amine (Cat.12) and 15 mol% of benzoic acid as an additive in toluene at room temperature. Under optimal reaction conditions target spirocyclopentaneoxindole derivatives (20) were obtained in excellent reaction yields (up to 86 %) and stereoselectivities (dr > 90 : 1, and ee > 99 %) (Scheme 16). [108] First, functionalized oxindole performs a Si-face nucleophilic attack on iminium-activated α,β-unsaturated alde-Scheme 24.…”
Section: Double Michael Cascade Reactionsmentioning
confidence: 99%
“…[11] Enantioenriched spiro derivatives [12] are characterized by the interesting fusion of two molecular rings linked by a common tetrasubstituted stereogenic center. They are an important component of several natural products, [13][14][15] bioactive compounds, [16][17][18][19][20] and find applications in asymmetric catalysis, [21][22][23][24] thermally stable OLED, [25][26][27][28][29][30][31] sensing, [32][33][34][35][36] and HMT (hole-transporting material). [37][38][39][40][41][42][43][44][45][46] Compared with singly condensed heterocycles spiro-hetero/carbocycles have the obvious advantage of structural compactness, which reduces lipophilicity.…”
Section: Introductionmentioning
confidence: 99%
“…Many compounds have been designed to target viral proteins: 3-(4-Pyridyl)-2-imidazolidinone derivatives (GPP3, EC 50 10 nM), licochalcone A (EC 50 9.30 μM), and aminothiazole derivatives (e.g., 12s , EC 50 0.27 μM) have been designed and synthesized using the enterovirus A71 CP as the target. Pyrazolopyridine analogues (e.g., 7a , EC 50 16.7 μM) are antiviral compounds targeting the enterovirus D68 CP . Heteroaryldihydropyrimidines (e.g., GLS4, EC 50 0.012 mM) are antiviral drugs that target the HBV CP and induce aberrant self-assembly, and GS-6207 (EC 50 105 pM) is an HIV replication inhibitor that targets the HIV-1 CP …”
Section: Introductionmentioning
confidence: 99%
“…Therefore, it is important to find nucleocapsid efficient and less toxic. Currently, several new HAP compoun RG7907(R07049389), are promising candidates for clinical trials [22,23 The molecular mechanism of action of CAMs is still unclear. To avoid the confusion in the literature about class I versus class II CAMs, depending on the mechanism of action [24,25], we will further use the nomenclature proposed by Wang S et al [26].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, it is important to find nucleocapsid modulators that are efficient and less toxic. Currently, several new HAP compounds, e.g., R10 and RG7907(R07049389), are promising candidates for clinical trials [ 22 , 23 ].…”
Section: Introductionmentioning
confidence: 99%